Prospects of gene therapy for genetic skeletal muscle disease

Karpati, 1993, The potential for gene therapy in muscular dystrophy and other genetic muscle diseases, Muscle & Nerve, 16, 1141, 10.1002/mus.880161102 Karpati, 1994, The principles of gene therapy in Duchenne muscular dystrophy, Clin Invest Med, 17, 499 Emery, 1988, Duchenne Muscular Dystrophy, 1 Tome, 1994, Congenital muscular dystrophy with merosin deficiency, CR Acad Sci Ser III Sci Vie, 317, 351 Kaplan, 1994, Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy, Cell, 78, 625, 10.1016/0092-8674(94)90527-4 Di Mauro, 1995, Biochemistry and molecular genetics of human glycogenoses: An overview, Muscle & Nerve, S510 Acsadi, 1995, The principles of gene therapy for genetic diseases of muscle (Duchenne dystrophy), spinal motor neurons (spinal muscular atrophy) and Schwann cells Schwannopathies), Clin Neurosci, 48, 76 Acsadi, 1995, Adenovirusmediated gene transfer into striated muscles, J Mol Med, 3, 579 Slater, 1994, The anatomy and physiology of the motor unit, 3 Walsh, 1994, Cell biology of muscle, 33 Karpati, 1990, Age-related conversion of dystrophin-negative to -positive fibre segments of skeletal but no cardiac muscle fibres in heterozygote mdx mice, J Neuropath Exp Neurol, 49, 96, 10.1097/00005072-199003000-00002 Carpenter, 1979, Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired, Brain, 102, 147, 10.1093/brain/102.1.147 Grounds, 1991, Towards understanding skeletal muscle regeneration, Pathol Res Pract, 118, 1, 10.1016/S0344-0338(11)81039-3 Acsadi, 1994, A different efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity, Hum Mol Genet, 3, 579, 10.1093/hmg/3.4.579 Acsadi, 1991, Human dystrophin expression in mdx mice after injection of DNA constructs, Nature, 352, 815, 10.1038/352815a0 Manthorpe, 1993, Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice, Hum Gene Ther, 4, 419, 10.1089/hum.1993.4.4-419 Yang, 1990, In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment, 87, 9568 Curiel, 1991, Adenovirus enhancement of transferrin-polylysin-mediated gene delivery, 88, 8850 Vincent, 1994, Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene, Nature Genet, 5, 130, 10.1038/ng1093-130 Ragot, 1993, Efficient adenovirusmediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice, Nature, 361, 647, 10.1038/361647a0 Alameddine, 1994, Expression of a recombinant dystrophin in mdx mice using adenovirus vector, Neuromusc Disord, 4, 193, 10.1016/0960-8966(94)90020-5 Acsadi, 1995, Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer, Hum Gene Ther Stratford-Perricaudet, 1992, Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector, J Clin Invest, 90, 626, 10.1172/JCI115902 Dunckley, 1992, Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro, FEBS Lett, 296, 128, 10.1016/0014-5793(92)80363-L Salvatori, 1993, Retroviral vector-mediated gene transfer into human primary myogenic cells lead to expression in muscle fiber in vivo, Hum Gene Ther, 4, 713, 10.1089/hum.1993.4.6-713 Berkner, 1988, Development of adenovirus vectors for the expression of heterologous genes, Bio Tech, 6, 616 Graham, 1992, Adenovirus-based expression vectors and recombinant vaccines, 363 Graham, 1987, Growth of 293 cells in suspension culture, J Gen Virol, 68, 937, 10.1099/0022-1317-68-3-937 Wickham, 1993, Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment, Cell, 73, 309, 10.1016/0092-8674(93)90231-E Jani, 1995, Generation and validation of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA, Virus Res Meth Yang, 1994, Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy, 91, 4407 Yang, 1995, Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses, J Virol, 69, 2004, 10.1128/JVI.69.4.2004-2015.1995 England, 1990, Very mild muscular dystrophy associated with the deletion of 46% of dystrophin, Nature, 343, 180, 10.1038/343180a0 Hauser, 1994, Expression of dystrophin minigenes in the muscles of mdx mice partially prevents the development of dystrophic symptoms, Am J Hum Genet, 55, A47 Cox, 1993, Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity, Nature, 364, 725, 10.1038/364725a0 Klamut, 1990, Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene, Molec Cell Biol, 10, 193, 10.1128/MCB.10.1.193 Huard, 1995, The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants, Gene Ther, 2, 107 Sicinski, 1989, The molecular basis of muscular dystrophy in the mdx mouse: a point mutation, Science, 244, 1578, 10.1126/science.2662404 Stedman, 1991, The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, 352, 536, 10.1038/352536a0 Kornegay, 1988, Muscular dystrophy in a litter of golden retriever dogs, Muscle & Nerve, 11, 1056, 10.1002/mus.880111008 Arahata, 1993, Laminin in animal models for muscular dystrophy: defect of laminin M in skeletal and cardiac muscle and peripheral nerve of the homozygous dystrophic dy/dy mice, 69B, 259 Sunada, 1994, Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus, JBiol Chem, 269, 13729, 10.1016/S0021-9258(17)36704-2 Angelos, 1995, Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle, Muscle & Nerve, 18, 736, 10.1002/mus.880180710 Wolff, 1992, Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle, Hum Mol Genet, 1, 363, 10.1093/hmg/1.6.363 Lochmuller, 1994, Emergence of early region 1 (E1)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔEl+ΔE3) during multiple passages in 293 cells, Hum Gene Ther, 5, 1485, 10.1089/hum.1994.5.12-1485 Danko, 1993, Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection, Hum Mol Genet, 2, 2055, 10.1093/hmg/2.12.2055 Huard, 1995, Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants, Am J Pathol Greber, 1993, Stepwise dismantling of adenovirus 2 during entry into cells, Cell, 75, 477, 10.1016/0092-8674(93)90382-Z Crystal, 1994, Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis, Nature Genet, 8, 42, 10.1038/ng0994-42 Morgan, 1994, Cell and gene therapy in Duchenne muscular dystrophy, Hum Gene Ther, 5, 165, 10.1089/hum.1994.5.2-165 Medical Research Council of Canada, 1990 1993, 921